CVS Health Reports First Quarter Results, Provides Update On COVID-19 Response 2020 Full Year EPS Guidance Remains Unchanged

Go back to CVS Health Reports First Quarter Results, Provides Update On COVID-19 Response 2020 Full Year EPS Guidance Remains Unchanged

CVS Health (CVS) Tops Q1 EPS by 28c, Maintains FY EPS Guidance

May 6, 2020 6:31 AM EDT

CVS Health (NYSE: CVS) reported Q1 EPS of $1.91, $0.28 better than the analyst estimate of $1.63. Revenue for the quarter came in at $66.8 billion versus the consensus estimate of $64.06 billion.

GUIDANCE:

CVS Health sees FY2020 EPS of $7.04-$7.17, versus the consensus of... More